Who has invested in BioSight?

Arkin Holdings, Primera Capital are named among the investors backing BioSight.

BioSight Funding: $63M Raised, Series C

BioSight funding overview

BioSight is based in Rehovot, Israel. BioSight has raised $63M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C. Investors on record include Arkin Holdings, Primera Capital. 2 distinct backers are named across the disclosed rounds.

BioSight at a glance

Total raised: $63M
Latest round: Series C
Headquarters: Rehovot, Israel
Notable investors: Arkin Holdings, Primera Capital

Frequently asked about BioSight funding

How much has BioSight raised?: BioSight has raised $63M in total disclosed funding across the rounds on record.
Who has invested in BioSight?: Arkin Holdings, Primera Capital are named among the investors backing BioSight.
What was the latest BioSight funding round?: The most recent disclosed round is a Series C.
Where is BioSight based?: BioSight is based in Rehovot, Israel.

We update the BioSight record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Rehovot and their backers are listed below.

BioSight Funding: $63M Raised, Series C

BioSight funding overview

BioSight at a glance

Frequently asked about BioSight funding

Companies related to BioSight (13)

Browse related funding lists (2)